BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 14530402)

  • 1. Systemic and cell type-specific gene expression patterns in scleroderma skin.
    Whitfield ML; Finlay DR; Murray JI; Troyanskaya OG; Chi JT; Pergamenschikov A; McCalmont TH; Brown PO; Botstein D; Connolly MK
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12319-24. PubMed ID: 14530402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subsets in the gene expression signatures of scleroderma skin.
    Milano A; Pendergrass SA; Sargent JL; George LK; McCalmont TH; Connolly MK; Whitfield ML
    PLoS One; 2008 Jul; 3(7):e2696. PubMed ID: 18648520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous antigen-stimulating lymphokine production by lymphocytes of patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Clin Invest; 1976 Dec; 58(6):1388-94. PubMed ID: 791970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affected and non-affected skin fibroblasts from systemic sclerosis patients share a gene expression profile deviated from the one observed in healthy individuals.
    Fuzii HT; Yoshikawa GT; Junta CM; Sandrin-Garcia P; Fachin AL; Sakamoto-Hojo ET; Donadi EA; Passos GA; Andrade LE
    Clin Exp Rheumatol; 2008; 26(5):866-74. PubMed ID: 19032821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement.
    Showalter K; Spiera R; Magro C; Agius P; Martyanov V; Franks JM; Sharma R; Geiger H; Wood TA; Zhang Y; Hale CR; Finik J; Whitfield ML; Orange DE; Gordon JK
    Ann Rheum Dis; 2021 Feb; 80(2):228-237. PubMed ID: 33028580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis.
    Gaydosik AM; Tabib T; Domsic R; Khanna D; Lafyatis R; Fuschiotti P
    Ann Rheum Dis; 2021 Nov; 80(11):1453-1460. PubMed ID: 34031030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA markers for susceptibility and expression in scleroderma.
    Gladman DD; Kung TN; Siannis F; Pellett F; Farewell VT; Lee P
    J Rheumatol; 2005 Aug; 32(8):1481-7. PubMed ID: 16078323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
    Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
    Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of ephrins and thrombospondins in the dermis of patients with early diffuse systemic sclerosis: potential contribution to perturbed angiogenesis and fibrosis.
    Avouac J; Clemessy M; Distler JH; Gasc JM; Ruiz B; Vacher-Lavenu MC; Wipff J; Kahan A; Boileau C; Corvol P; Allanore Y
    Rheumatology (Oxford); 2011 Aug; 50(8):1494-504. PubMed ID: 21454305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.
    Hasegawa M; Hamaguchi Y; Yanaba K; Bouaziz JD; Uchida J; Fujimoto M; Matsushita T; Matsushita Y; Horikawa M; Komura K; Takehara K; Sato S; Tedder TF
    Am J Pathol; 2006 Sep; 169(3):954-66. PubMed ID: 16936269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.
    Arakawa H; Jinnin M; Muchemwa FC; Makino T; Kajihara I; Makino K; Honda N; Sakai K; Fukushima S; Ihn H
    Exp Dermatol; 2011 Sep; 20(9):764-6. PubMed ID: 21615510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma.
    Zhou L; Askew D; Wu C; Gilliam AC
    J Invest Dermatol; 2007 Feb; 127(2):281-92. PubMed ID: 16917493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progranulin Overproduction Due to Fli-1 Deficiency Contributes to the Resistance of Dermal Fibroblasts to Tumor Necrosis Factor in Systemic Sclerosis.
    Ichimura Y; Asano Y; Akamata K; Noda S; Taniguchi T; Takahashi T; Toyama T; Tada Y; Sugaya M; Sato S; Kadono T
    Arthritis Rheumatol; 2015 Dec; 67(12):3245-55. PubMed ID: 26245842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophenotyping of chimeric cells in localized scleroderma.
    McNallan KT; Aponte C; el-Azhary R; Mason T; Nelson AM; Paat JJ; Crowson CS; Reed AM
    Rheumatology (Oxford); 2007 Mar; 46(3):398-402. PubMed ID: 17085771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies.
    Pendergrass SA; Lemaire R; Francis IP; Mahoney JM; Lafyatis R; Whitfield ML
    J Invest Dermatol; 2012 May; 132(5):1363-73. PubMed ID: 22318389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Iannone F; Matucci-Cerinic M; Falappone PC; Guiducci S; Cinelli M; Distler O; Lapadula G
    J Rheumatol; 2005 Oct; 32(10):1893-8. PubMed ID: 16206343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of monocyte and lymphocyte messenger RNA expression with serum protein profiles in patients with scleroderma.
    Duan H; Fleming J; Pritchard DK; Amon LM; Xue J; Arnett HA; Chen G; Breen P; Buckner JH; Molitor JA; Elkon KB; Schwartz SM
    Arthritis Rheum; 2008 May; 58(5):1465-74. PubMed ID: 18438864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA class II antigens on skin fibroblasts in scleroderma.
    Branchet MC; Boisnic S; Blétry O; Robert L; Charron D; Francès C
    Br J Dermatol; 1992 May; 126(5):431-5. PubMed ID: 1610682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16.
    Mondini M; Vidali M; De Andrea M; Azzimonti B; Airò P; D'Ambrosio R; Riboldi P; Meroni PL; Albano E; Shoenfeld Y; Gariglio M; Landolfo S
    Arthritis Rheum; 2006 Dec; 54(12):3939-44. PubMed ID: 17133607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.